Articles

Poll

Podcasts

Slideshows

Videos

A study presented at SLEEP 2025 found longer and more variable napping patterns are associated with increased all-cause mortality in middle-to-older aged adults.


Naps at Noon Linked to Mortality Risk in Older Adults, with Chenlu Gao, PhD

At SLEEP 2025, Fung shared that masked taper plus CBT-I led to higher benzodiazepine discontinuation and improved sleep in older adults.

Masked Taper + CBT-I Boosts Benzodiazepine Discontinuation, with Constance Fung, MD

Disrupted circadian rest-activity rhythms were tied to faster biological aging in older adults, independent of age, sex, or race, new study shows.

Weaker Circadian Rhythms Linked to Accelerated Biological Aging, Study Finds

New findings reveal that timing of antihypertensive medication—bedtime vs. morning—shows no significant impact on health outcomes for frail older adults.

Bedtime vs Morning Dosing of Blood Pressure Meds Shows No Benefit in Frail Elderly

Discover effective treatments for bunions in older adults, including advanced surgical options and minimally invasive techniques to enhance mobility and quality of life.

Advances in Surgical Interventions for Aging Patients with Bunions

Advanced biological aging significantly associated with the dementia risk, a new study found.

 Biological Aging May Be a Risk Factor for Incident Dementia

New research reveals older adults face higher anaphylaxis risks from medications and IV contrast, often presenting with severe symptoms and outcomes.

Medications, IV Contrasts Increase Anaphylaxis Odds in Older Adults

Parkinson’s is often diagnosed after symptoms of the disease have already begun to appear; these results may lead to a more preemptive indication of pathogenesis.

Retinal Response Testing May Help Early Diagnosis of Parkinson’s Disease

New research links high smoke pollution to increased respiratory hospitalizations in older adults, highlighting urgent health risks from wildfires.

Wildfire Smoke Tied to More Respiratory Hospitalizations in Older Adults

The FDA granted fast-track status to Biogen’s BIIB080, a tau-targeting therapy for Alzheimer Disease, which is now being evaluated in the global phase 2 CELIA study.

FDA Grants Fast Track to Biogen’s Tau-Targeting BIIB080 for Alzheimer Disease

Dementia and Alzheimer Disease

Alzheimer Disease condition center page, resources on the topics of medical news and expert insight into Alzheimer's can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dementa and Alzheimer disease research, treatment, and drug development.

Parkinson Disease

The HCPLive Parkinson's disease page is a comprehensive resource for clinical news and insights on PD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for movement disorders, and more.

Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.